GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Jiangxi Rimag Group Co Ltd (HKSE:02522) » Definitions » Debt-to-EBITDA

Jiangxi Rimag Group Co (HKSE:02522) Debt-to-EBITDA : 14.01 (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Jiangxi Rimag Group Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Jiangxi Rimag Group Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was HK$209.7 Mil. Jiangxi Rimag Group Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2024 was HK$255.7 Mil. Jiangxi Rimag Group Co's annualized EBITDA for the quarter that ended in Jun. 2024 was HK$33.2 Mil. Jiangxi Rimag Group Co's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2024 was 14.01.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Jiangxi Rimag Group Co's Debt-to-EBITDA or its related term are showing as below:

HKSE:02522' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -3.86   Med: 1.51   Max: 27.32
Current: 27.32

During the past 3 years, the highest Debt-to-EBITDA Ratio of Jiangxi Rimag Group Co was 27.32. The lowest was -3.86. And the median was 1.51.

HKSE:02522's Debt-to-EBITDA is ranked worse than
95.76% of 448 companies
in the Healthcare Providers & Services industry
Industry Median: 2.465 vs HKSE:02522: 27.32

Jiangxi Rimag Group Co Debt-to-EBITDA Historical Data

The historical data trend for Jiangxi Rimag Group Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangxi Rimag Group Co Debt-to-EBITDA Chart

Jiangxi Rimag Group Co Annual Data
Trend Dec21 Dec22 Dec23
Debt-to-EBITDA
-3.86 2.32 1.51

Jiangxi Rimag Group Co Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24
Debt-to-EBITDA N/A N/A - 486.43 14.01

Competitive Comparison of Jiangxi Rimag Group Co's Debt-to-EBITDA

For the Medical Care Facilities subindustry, Jiangxi Rimag Group Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiangxi Rimag Group Co's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Jiangxi Rimag Group Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Jiangxi Rimag Group Co's Debt-to-EBITDA falls into.



Jiangxi Rimag Group Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Jiangxi Rimag Group Co's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(180.225 + 241.994) / 280.229
=1.51

Jiangxi Rimag Group Co's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(209.65 + 255.735) / 33.208
=14.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Jun. 2024) EBITDA data.


Jiangxi Rimag Group Co  (HKSE:02522) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Jiangxi Rimag Group Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Jiangxi Rimag Group Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiangxi Rimag Group Co Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Minzuyuan Road, Building 2, 2 Minzuyuan, 3rd Floor, Chaoyang District, Beijing, CHN
Jiangxi Rimag Group Co Ltd is a leading medical group specializing in medical imaging in China. the company generates revenue mainly through the following medical imaging services and solutions: Imaging Center Services, Imaging Solution Services, and Rimag Cloud Services. The Imaging Center Services include examination and diagnostic services to patients and other healthcare consumers via its flagship imaging centers, such as MRI, CT, PET, X-ray, ultrasound and mammography.
Executives
Beijing Goldman Sachs Consulting Co., Ltd. 2101 Beneficial owner
Goldman Sachs & Co. Llc 2201 Interest of corporation controlled by you
Goldman Sachs Holdings (mauritius) Limited 2201 Interest of corporation controlled by you
Gs Asian Venture (delaware) L.l.c. 2201 Interest of corporation controlled by you
Gssg Holdings Llc 2201 Interest of corporation controlled by you
Special Situations Investing Group Iii, Inc. 2201 Interest of corporation controlled by you
The Goldman Sachs Group, Inc. 2201 Interest of corporation controlled by you
Tiger Strategic Investments Ltd 2201 Interest of corporation controlled by you

Jiangxi Rimag Group Co Headlines

No Headlines